Aspirin on par with dalteparin in preventing VTE after hip replacement

06/4/2013 | Medscape (free registration)

Aspirin performed comparably to dalteparin in preventing venous thromboembolism following total hip arthroplasty, according to a 778-patient study in the Annals of Internal Medicine. There were no major bleeding events in the group given aspirin, while there was one case in the dalteparin group. Clinically significant nonmajor bleeding and minor bleeding were reported more often in the dalteparin group than the aspirin group.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA